Attention Deficit/Hyperactivity Disorder (ADHD) Mental and Behavioural Disorders Disturbance of activity and attention
Conditions
Interventions
After randomisation, the treatment group will be given 40 sessions of 1 hour per session of neurofeedback at the Mental Capital Care clinic in Helsinki. Baseline, post-treatment and follow-up measurem
Sponsors
University of Helsinki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pre-existing diagnosis of ADHD 2. Nonexistence of neurological diagnoses 3. IQ score > 80 measured by a qualified psychologist using WAIS IV 4. Scores on ASRS and BADDS indicating presence of ADHD
Exclusion criteria
Exclusion criteria: Extreme outlier scores in the scales of 1. Generalized Anxiety Disorder (Spitzer et al., 2006) 2. Beck Depression Inventory (Beck et al., 1996) 3. Alcohol Use Disorders Identification Test (Saunders et al., 1993) 4. The Mood Disorder Questionnaire (Robert et al., 2000) 5. Test of prodromal symptoms of psychosis (Heinimaa et al., 2003) 6. Dissociative experiences scale (Liebowitz, 1992) for dissociative symptoms Thresholds for exclusion were not fixed but at the discretion of the consulting psychiatrist. Use of medication for ADHD was not an exclusion criterion but participants were asked not to make changes in medication during the time of the training.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Self-report of ADHD symptoms, using Brown Attention Deficit Disorder Scale (BADDS) to be measured at baseline, post-treatment 1 year after baseline, and follow-up 2.5 years after treatment 2. Adult ADHD Self Report Scale (ASRS) to be measured at the same timepoints as BADDS 3. Objective measure of attention, using the computerised Test Of Variables of Attention (TOVA), to be completed at baseline and post-treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment group records of performance during neurofeedback ('learning curves'). | — |
Countries
Finland
Outcome results
None listed